title: Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis.
abstract: Protein-tyrosine phosphatases (PTPases) play an integral role in the regulation of cellular insulin action. LAR, a transmembrane PTPase expressed in insulin-sensitive tissues, acts as a negative regulator of insulin signaling in intact cell models. The physiological role of LAR was studied in mice in which LAR expression was eradicated by insertional mutagenesis. In the fasting state, adult male homozygous LAR (-/-) mice had significantly lower plasma levels of insulin and glucose, as well as a reduced rate of hepatic glucose production compared with wild-type controls, suggesting a heightened level of insulin sensitivity. In euglycemic clamp studies, the LAR (-/-) mice exhibited a significant resistance to insulin-stimulated glucose disposal and suppression of hepatic glucose output. Examination of hepatic insulin action demonstrated that the major alteration involved a 47% reduction in insulin-stimulated phosphatidylinositol 3'-kinase (PI 3-kinase) activity in the knockout mice, indicating a post-receptor signaling defect. Taken together with previous work on the cellular effects of LAR, the present results are consistent with a physiological role for LAR in the negative regulation of insulin action, with secondary abnormalities that contribute to the resistance to insulin-stimulated signaling in the knockout mice. Overall, these data provide further evidence for an important role for LAR in the regulation of insulin action and glucose homeostasis in intact animals.
authors.affiliation: Institute for Metabolic Disorders, Bayer Corporation, West Haven, Connecticut, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Ren
authors.forename: P M
authors.initials: PM
authors.lastname: Li
authors.forename: W R
authors.initials: WR
authors.lastname: Zhang
authors.forename: L J
authors.initials: LJ
authors.lastname: Sweet
authors.forename: G
authors.initials: G
authors.lastname: Cline
authors.forename: G I
authors.initials: GI
authors.lastname: Shulman
authors.forename: J N
authors.initials: JN
authors.lastname: Livingston
authors.forename: B J
authors.initials: BJ
authors.lastname: Goldstein
mesh_terms: D000818:Animals; D015331:Cohort Studies; D015971:Gene Expression Regulation, Enzymologic / Q000235:genetics*; D005947:Glucose / Q000378:metabolism*; D015309:Glucose Clamp Technique; D006706:Homeostasis; D055504:Insulin Receptor Substrate Proteins; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D010641:Phenotype; D019869:Phosphatidylinositol 3-Kinases / Q000187:drug effects / Q000378:metabolism; D010750:Phosphoproteins / Q000032:analysis / Q000187:drug effects; D017027:Protein Tyrosine Phosphatases / Q000235:genetics* / Q000378:metabolism*; D051381:Rats; D011972:Receptor, Insulin / Q000187:drug effects / Q000378:metabolism
chemical_list: D055504:Insulin Receptor Substrate Proteins; C526295:Irs1 protein, mouse; C526296:Irs1 protein, rat; D010750:Phosphoproteins; D019869:Phosphatidylinositol 3-Kinases; D011972:Receptor, Insulin; D017027:Protein Tyrosine Phosphatases; D005947:Glucose